Skip to content
  • Contact
  • Book a Consult
logo virtue 340b white trademark
  • 340B Risk Management
    • 340B Risk Management
    • Independent 340B Audits
    • 340B Continuous Monitoring
  • 340B Consulting Services
    • Overview of Services
    • Tailored 340B Education Programs
    • Manufacturer Restrictions Management at Contract Pharmacies
    • Contract Pharmacy Opportunity Analysis
    • Referral Capture Policy and Parameters
    • Third-Party Administrator Configuration Standardization
  • Covered Entities
    • Overview of Covered Entities
    • Health Systems and Large Hospitals
    • Rural Hospitals
    • Federally Qualified Health Centers and Grantees
  • Content Hub
    • Overview of 340B Resources
    • 340B Mastery Book
    • Closing the Visibility Gap
    • Blog
    • Katy’s Compass
    • 340B Newsletter
    • Glossary
  • About Us
    • About Us
    • Vision & Mission
    • Team
    • Awards and Partnerships
    • FAQ
  • Book a Consult
logo virtue 340b white trademark
  • Home
  • Independent 340B Audits
  • 340B Continuous Monitoring Program
  • 340B Consulting Services
    • Tailored 340B Education Programs
    • Third-Party Administrator Configuration Standardization
    • Manufacturer Restrictions Management at Contract Pharmacies
    • Contract Pharmacy Opportunity Analysis
    • Referral Capture Policy and Parameters
  • Covered Entities
    • Health Systems and Large Hospitals
    • Rural Hospitals
    • Federally Qualified Health Centers and Grantees
  • Content Hub
    • 340B Mastery Book
    • Blog
    • Katy’s 340B Compass
    • 340B Newsletter
    • Glossary
  • About Us
    • About Us
    • Team
    • Vision & Mission
    • Awards and Partnerships
    • FAQ
  • Contact Us
×
  • Home
  • Independent 340B Audits
  • 340B Continuous Monitoring Program
  • 340B Consulting Services
    • Tailored 340B Education Programs
    • Third-Party Administrator Configuration Standardization
    • Manufacturer Restrictions Management at Contract Pharmacies
    • Contract Pharmacy Opportunity Analysis
    • Referral Capture Policy and Parameters
  • Covered Entities
    • Health Systems and Large Hospitals
    • Rural Hospitals
    • Federally Qualified Health Centers and Grantees
  • Content Hub
    • 340B Mastery Book
    • Blog
    • Katy’s 340B Compass
    • 340B Newsletter
    • Glossary
  • About Us
    • About Us
    • Team
    • Vision & Mission
    • Awards and Partnerships
    • FAQ
  • Contact Us

Home » Archives for

Posts by Jenna Burns

Albany Med v. HRSA: What the Decision Really Means for 340B Child Site Eligibility

By Jenna Burns | March 27, 2026
340B Eligible Medications

A federal court ruling in Albany Med v HRSA is reshaping how 340B child site eligibility is evaluated. While registration may no longer define eligibility, organizations must now clearly document and defend how sites qualify under the program.

Read More

Recent Posts

  • 340B Growth in Context: What the Data Shows, and Why the Narrative Matters
  • Why Independent Oversight Matters in Vendor-Managed 340B Programs
  • Albany Med v. HRSA: What the Decision Really Means for 340B Child Site Eligibility
  • Virtue 340B partners with HANYS Marketplace
  • Why 340B Matters: A Response to PhRMA’s Middleman Narrative

Recent Comments

No comments to show.

Contact

585-329-0280

Ontario, NY 14519

contact.virtue@virtue340b.com

Additional Resources

  • Contact
  • Privacy Policy
  • Terms of Service
  • Business Facts: Virtue 340B
CIA Badge Image
340BACE-Logo
HANYS Marketplace logo — Virtue 340B healthcare partnership

© 2026 Virtue 340B. All Rights Reserved.

Scroll To Top